| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |